PHASERX owner Contact Information online
from PhaseRx, Inc.
PHASERX
The mark consists of a horseshoe shape with a circle inside where the horseshoe and circle contain unevenly spaced horizontal lines followed by the word "PhaseRx".
US serial number:85107296
Application filling date:Aug. 13, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Aug. 04, 2014
Publication date:May 03, 2011
Abandoned date:Aug. 04, 2014
Standard character claim:No
Mark drawing type:3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Goods and services:For: Pharmaceutical preparations, namely, polymeric delivery technologies in the form of powders or liquid solutions for the targeted delivery of macromolecules and pharmaceutical preparations for medical purposes
International Class(es): 005- Primary Cla
Services:Pharmaceutical preparations
namely
polymeric delivery technologies in the form of powders or liquid solutions for the targeted delivery of macromolecules and pharmaceutical preparations for medical purposes
Current owner owner name:PhaseRx, Inc.
Current owner owner address:410 W. Harrison Street, Suite 300
Seattle,
WASHINGTON
UNITED STATES
98119
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Louis C. Cullman
Attorney email:ocipgroup@klgates.com
Attorney docket number:1958510.0001
Attorney email authorized:Yes
Correspondent name address:LOUIS C. CULLMAN
K&L GATES LLP
1 Park Plaza, 12th Floor
IRVINE,
CALIFORNIA
UNITED STATES
92614-7319
Correspondent phone:949-253-0900
Correspondent email:chicago.trademarks@klgates.com
Correspondent fax:949-253-0902
Correspondent email authorized:Yes
Trademark staff tm attorney:HSU, FONG
Trademark staff law office assigned PHASERX:LAW OFFICE 117
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (42) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
May 03, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
